October is American Pharmacists Month, and we’ve teamed up with the International Pharmaceutical Federation (FIP) to bring you an interview with Dr. Catherine Duggan, CEO, about how pharmacists and the pharmaceutical industry at large can contribute to the fight against antimicrobial resistance.
Because microbes that infect animals can often infect humans as well, it is important to understand how antimicrobial resistance develops in animal populations, especially populations in close contact with people such as livestock.
Barb Hammond, a microbiologist at bioMérieux who has been with the company for more than 30 years, loves being outdoors, spending time with her family, and training her golden retriever in competitive dog sports. But last year, Barb’s usual routine came to screeching halt when she became septic after a surgical procedure.
COVID-19 is not just any respiratory virus. Researchers have quickly discovered that it is capable of directly affecting multiple organ systems, and that it can also cause a host of related complications. Among those complications are endothelial dysfunction, sepsis, and acute kidney injury.